Items where Author is "Davis, Courtney"

Davis, Courtney, Wagner, Anita K., Mintzes, Barbara, Scowcroft, Henry, Woloshin, Steven and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2024) Patients deserve better information on new drugs. BMJ (Clinical research ed.), 387. ISSN 0959-8146

Cherla, Avi, Davis, Courtney, Mossialos, Elias ORCID: 0000-0001-8664-9297 and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Faster UK drug approvals by relying on other countries. BMJ (Clinical research ed.), 381. p. 739. ISSN 1756-1833

Davis, Courtney, Wagner, Anita K., Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Scowcroft, Henry, Mintzes, Barbara, Pokorny, Adrian M J, Lew, Jianhui and Naci, Huseyin ORCID: 0000-0002-7192-5751 (2023) Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. BMJ, 380. e073711. ISSN 0959-8138

Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Naci, Huseyin ORCID: 0000-0002-7192-5751 and Davis, Courtney (2020) Approval of cancer drugs with uncertain therapeutic value: a comparison of regulatory decisions in Europe and the United States. Milbank Quarterly, 98 (4). 1219 - 1256. ISSN 0887-378X

Naci, Huseyin ORCID: 0000-0002-7192-5751, Davis, Courtney, Savović, Jelena, Higgins, Julian P. T., Sterne, Jonathan, Gyawali, Bishal, Romo Sandoval, Xochitl Citlalli, Handley, Nicola and Booth, Christopher M (2019) Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross-sectional analysis. BMJ, 366 (8214). ISSN 1756-1833

Davis, Courtney, Naci, Huseyin ORCID: 0000-0002-7192-5751, Gurpinar, Evrim, Poplavska, Elita, Pinto, Ashlyn and Aggarwal, Ajay (2017) Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13. BMJ, 359 (359). ISSN 1756-1833